-
Apple sued by BASF spin-off over face recognition tech in Western District of Texas
Read more: Apple sued by BASF spin-off over face recognition tech in Western District of TexasPlaintiff trinamiX was established by BASF to commercialize discoveries around advanced sensing, including optical skin recognition.
-
UPC Roundup (1 week): CoA limits evidence-preservation questioning; Dusseldorf LD extends injunction to UK; and more
Read more: UPC Roundup (1 week): CoA limits evidence-preservation questioning; Dusseldorf LD extends injunction to UK; and moreThis is a summary of developments in and around the UPC in the calendar week of August 31, 2026.
-
EPO Enlarged Board limits mandatory description amendments in G 1/25
Read more: EPO Enlarged Board limits mandatory description amendments in G 1/25The EPO Enlarged Board of Appeal has ruled that amended claims do not automatically require corresponding changes to the description, while reinforcing the description’s role in claim interpretation.
-
Podcast: interview with WIPO’s Heike Wollgast on SEP mediation pledge, role of alternative dispute resolution in patent litigation
Read more: Podcast: interview with WIPO’s Heike Wollgast on SEP mediation pledge, role of alternative dispute resolution in patent litigationIn our latest podcast episode, ip fray interviewed Heike Wollgast, who heads up the IP Disputes Section of the World Intellectual Property Organization’s Arbitration and Mediation Center.
-
From portfolio growth to commercial value: the next stage of Türkiye’s patent growth
Read more: From portfolio growth to commercial value: the next stage of Türkiye’s patent growthFollowing the 31% rise in Türkiye’s domestic patent filings, we analyze the shift from portfolio growth toward commercially valuable patents, the limits on international filings, and the country’s emerging SEP capabilities with Vestel IP head Kemal Aygör.
-
Accord slapped with injunction in Munich after invalidity losses in EPO, German Federal Patent Court
Read more: Accord slapped with injunction in Munich after invalidity losses in EPO, German Federal Patent CourtThe Munich I Regional Court has found that Accord infringed TOWA’s dabigatran etexilate patent, issuing an injunction against the company. Dabigatran etexilate is an oral anticoagulant medicine that stops blood clots from forming, preventing strokes, deep vein thrombosis, and pulmonary embolism, among other things.
-
Patent owner asks USPTO Director to terminate Google-triggered reexam, points to pattern of 21 do-overs after failed IPRs
Read more: Patent owner asks USPTO Director to terminate Google-triggered reexam, points to pattern of 21 do-overs after failed IPRsA patent owner has asked the USPTO Director to end a Google-triggered reexam, citing a pattern in which Google filed at least 21 ex parte reexams after losing IPR challenges.
-
UPC’s CD Munich: co-inventorship is not enough to revoke a patent for lack of entitlement
Read more: UPC’s CD Munich: co-inventorship is not enough to revoke a patent for lack of entitlementThe CD Munich held that Art. 138(1)(e) EPC requires proof that the proprietor has no rights at all, so demonstrating co-inventorship cannot support revocation. The wind turbine patent is maintained as amended, less two dependent claims held insufficiently disclosed.
Follow Us
Latest Articles
- Apple sued by BASF spin-off over face recognition tech in Western District of Texas
- UPC Roundup (1 week): CoA limits evidence-preservation questioning; Dusseldorf LD extends injunction to UK; and more
- EPO Enlarged Board limits mandatory description amendments in G 1/25
- Podcast: interview with WIPO’s Heike Wollgast on SEP mediation pledge, role of alternative dispute resolution in patent litigation
- From portfolio growth to commercial value: the next stage of Türkiye’s patent growth